Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

1(11%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

33%

Ph phase_3

11%

Ph phase_1

11%

Ph phase_4

11%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

3(33.3%)

Phase 3Large-scale testing

1(11.1%)

Phase 4Post-market surveillance

1(11.1%)

N/ANon-phased studies

3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(5)

Terminated(2)

Detailed Status

Completed5

Withdrawn2

Not yet recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (11.1%)

Phase 23 (33.3%)

Phase 31 (11.1%)

Phase 41 (11.1%)

N/A3 (33.3%)

Trials by Status

not_yet_recruiting111%

withdrawn222%

recruiting111%

completed556%

Recent Activity

1 active trials

Showing 5 of 9

not_yet_recruitingnot_applicable

Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva

NCT05364515

completedphase_4

Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination

NCT03231137

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT07773740Not Applicable

Autologous Plasma Rich in Growth Factors for Severe Dry Eye Disease

Not Yet Recruiting

NCT03943680Not Applicable

Plasma Rich in Growth Factors in Post-extraction Sockets

Completed

NCT06261346Not Applicable

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation

Recruiting

NCT05364515Phase 3

Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva

Withdrawn

NCT03231137Phase 4

Socket Augmentation Using Platelet Concentrates, Atorvastatin Gel or Combination

Completed

NCT00731068Phase 2

Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears

Completed

NCT01152658Phase 1

Partial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF)

Withdrawn

NCT00728611Phase 2

Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee

Completed

NCT00726245Phase 2

Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

Completed

All 9 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 9